PHI with Degenerative basal ganglia diseases
How does this condition affect your private health insurance?
Degenerative diseases of the basal ganglia are a group of progressive neurological disorders marked by neuron loss in brain regions vital for motor control, learning, and executive functions. Prominent examples include Parkinson's disease, Huntington's disease, and atypical parkinsonian syndromes. Symptoms typically involve movement abnormalities like tremors, rigidity, bradykinesia, dystonia, or chorea, frequently accompanied by cognitive decline, psychiatric issues, and autonomic dysfunction. While some cases have genetic roots, the exact cause is often unknown. These conditions lead to a gradual and irreversible deterioration of both motor and cognitive abilities over time, profoundly impacting quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Insidious onset, with initial subtle symptoms developing over months to a few years before clinical diagnosis.
Duration of Illness (Lifetime)
Chronic, progressive, and lifelong, typically spanning decades.
Cost of Treatment (Initial)
Moderate to high (e.g., thousands to tens of thousands of euros for specialist consultations, diagnostics, and initial medication).
Cost of Treatment (Lifetime)
Very high, often hundreds of thousands to millions of euros due to ongoing medication, therapies, assistive devices, and long-term care needs.
Mortality Rate
Increased, particularly in advanced stages due to complications such as aspiration pneumonia, falls, immobility-related issues, and systemic decline.
Risk of Secondary Damages
Very high, including severe physical disability, chronic pain, cognitive impairment (dementia), psychological distress (depression, anxiety), falls, dysphagia, and autonomic dysfunction.
Probability of Full Recovery
Virtually none; these diseases are inherently progressive and irreversible, with no known cure.
Underlying Disease Risk
Variable; while some forms have specific genetic mutations (e.g., Huntington's), many sporadic cases have no clear "underlying disease" but are often associated with age-related comorbidities.